# FDA Inspection 1240813 - Cipla Limited - June 21, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/cipla-limited/8bbdb860-88af-47ff-ac3a-04cb8bedbcad/
Source feed: FDA_Inspections

> FDA Inspection 1240813 for Cipla Limited on June 21, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240813
- Company Name: Cipla Limited
- Inspection Date: 2024-06-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1178952 - 2022-08-26](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/dc52b0e2-2947-4e2d-9bdf-1a9dc7fb515e/)
- [FDA Inspection 1103305 - 2019-09-27](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/8e4dda74-73d5-4f2e-853a-19cf3d2511d5/)
- [FDA Inspection 1103305 - 2019-09-27](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/3d4ad184-ec01-4b07-8d4c-c5a5edc56a1a/)
- [FDA Inspection 1078911 - 2019-01-28](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/f442d154-0a0c-46ea-ba3d-7b670aa57332/)
- [FDA Inspection 1078911 - 2019-01-28](https://www.globalkeysolutions.net/api/records/fda_inspections/cipla-limited/40022821-c763-46fa-bc75-58ecaf478d52/)

Company: https://www.globalkeysolutions.net/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c